Source comparison
Tesamorelin Dosing Timing: Clinical vs Practical Approaches
Evening (30–60 min before bed) Aligns with natural nocturnal GH surge (90–120 min post-injection during deep sleep) Optimal. 18–22% reduction in VAT at 26 weeks in Phase 3 trials Minimal disruption. GH pulse occurs during established sleep High. Most consisten
This comparison does not assign a generated winner or score.
- Evening (30–60 min before bed)
- Aligns with natural nocturnal GH surge (90–120 min post-injection during deep sleep)
- Optimal. 18–22% reduction in VAT at 26 weeks in Phase 3 trials
- Minimal disruption. GH pulse occurs during established sleep
- High. Most consistent with daily routines
- Gold standard for therapeutic outcomes
- Late evening (immediately before bed)
- GH pulse occurs during sleep onset, may slightly delay deep sleep entry
- Near-optimal. 15–19% VAT reduction
- Possible mild sleep latency increase in first 2 weeks
- High. Easier adherence for shift workers
- Acceptable alternative if 60-min window not feasible
- Morning (upon waking)
- GH pulse occurs during cortisol peak, when endogenous GH is suppressed
- Suboptimal. 10–14% VAT reduction
- No impact on sleep architecture
- Moderate. Conflicts with fasting protocols
- Avoid unless evening dosing impossible
- Midday (12:00–16:00)
- GH pulse during period of lowest natural secretion
- Poor. 8–12% VAT reduction
- No direct impact
- Low. Requires refrigeration access for reconstituted solution
- Not recommended. Defeats circadian alignment